Characteristics

Patients who received

any shock

(n = 380)

Patients who received any

appropriate shock

(n = 296)

Patients who received any

Inappropriate shock

(n=72)

Patients who received

no shock

(n = 40)

Age-Group in years

60-64

60-64

60-64

65-69

Ejection Fraction (%)

31±13

30.2 ± 12

33±14

28.4±10.4

NYHA Class -III

6.1 (23)

6.1 (18)

5.6 (4)

7.5 (3)

Male Gender

78.7 (299)

78.4 (232)

80.6 (58)

85 (34)

Congestive Heart Failure

49.2 (187)

49.3 (146)

50 (36)

55 (22)

Diabetes

21.8 (83)

22 (65)

16.7 (12)

37.5 (15)

Hypertension

53.4 (203)

56.7 (168)

40.3 (29)

57.5 (23)

Atrial Fibrillation/Flutter

24.7 (94)

22.6 (67)

31.9 (23)

15 (6)

History of Myocardial Infarction

70 (266)

70.2 (208)

69.4 (50)

85 (34)

History of CABG*

28.9 (110)

29.7 (88)

30.6 (22)

45 (18)

Smoking

22.6 (86)

21.3 (63)

29.2 (21)

27.5 (11)

ACE Inhibitor therapy

74.9 (285)

74.6 (221)

72.2 (52)

75 (30)

Aspirin therapy

60 (228)

60.1 (178)

61.1 (44)

65 (26)

Lipid lowering therapy

12.9 (49)

13.2 (39)

12.5 (9)

30 (12)

Beta Blocker therapy

35 (133)

33.5 (99)

40.3 (29)

40 (16)


[All values are % or n (mean ± SD)]
NYHA – New York Heart Association
*CABG – Coronary Artery Bypass Grafting
Table 1: Baseline clinical characteristics of study groups.